Upstream Bio Launches With $200M Series A Financing To Advance Novel Therapeutics For Allergic And Inflammatory Diseases
Amount Raised
$200 Million
Round Type
Series A
WalthamBiotechnologyHealth CareScience And EngineeringDescription
Upstream Bio, a biotech company focused on inflammation, today debuted with a $200 million Series A financing. The funding will allow Upstream to advance the company’s lead program UPB-101, a clinical-stage monoclonal antibody targeting the TSLP receptor, and build a pipeline of assets to address immune-mediated diseases. The Series A round was led jointly by OrbiMed and Maruho Co., Ltd. with participation from Access Biotechnology, Decheng Capital, HBM Healthcare Investments, TCG X, Omega Funds, Samsara BioCapital, and Altshuler Shaham Provident Funds Ltd.
Quick answer
Upstream Bio raised $200 Million in a Series A round, dated June 2, 2022. Upstream Bio is based in Waltham, Massachusetts, United States.
- How much did Upstream Bio raise?
- Upstream Bio raised $200 Million in a Series A round on June 2, 2022.
- What does Upstream Bio do?
- At Upstream Bio we strive to reach the source of inflammation and conquer it.
- Where is Upstream Bio based and how big is it?
- Upstream Bio is based in Waltham, Massachusetts, United States. Fundz records about 75 employees.
- Who are the decision-makers at Upstream Bio?
- Fundz holds 1 contact at Upstream Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Upstream Bio that raised within 45 days of this round, from Fundz verified event records.
- Agomab raised $41M (Series B) on July 13, 2022.
- Advanced NanoTherapies raised $7.2M (Series A) on June 28, 2022.
- PineTree Therapeutics raised $24M (Series A) on June 7, 2022.
- OliX Pharmaceuticals raised $45M (Funding Round) on May 25, 2022.
- 22nd Century raised $58M on May 25, 2022.
- Vyriad raised $30M (Series B) on May 17, 2022.
Who to call at Upstream Bio, and when
A new round usually means Upstream Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Upstream Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Upstream Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Upstream Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Upstream Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansUpstream Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.